We are monitoring the impact of COVID-19 on APAC Insulin Delivery Devices Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 229
Share on
Share on

Asia Pacific Insulin Delivery Devices Market Analysis - By Type, Application, Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) – Industry Analysis on Size, Share, Trends, Growth, Forecast (2021 to 2026)

Pulished: April, 2021
ID: 229
Pages: 145

APAC Insulin Delivery Devices Market Size (2021 to 2026)

The size of the Asia Pacific insulin delivery devices market is projected to grow USD 4.53 billion by 2026 from USD 3.32 billion in 2021, witnessing a growth rate of 6.40% from 2021 to 2026.

Insulin maintains the sugar levels in the blood and is essential for people who have type I diabetes & type II diabetes. Therefore, the development of insulin delivery devices has been encouraged in the past years. These devices are used to deliver insulin doses via the parenteral route rather than the oral route of administration. Insulin delivery devices promote the absorption rate of insulin into the bloodstream from injection to execute immediate pharmacological action of insulin. Some of the majorly used insulin delivery devices include insulin syringes, insulin pens, insulin pen needles, insulin pumps, and insulin jet injectors.

The rising number of pre-diabetic & large diabetic patient population, growing distribution networks of foreign manufacturers in this region, presence of favorable regulatory frameworks, availability of significant medical reimbursements, and increasing expansions of advanced medical facilities in certain Asian countries (China & India) are driving the growth of insulin delivery devices market in Asia-Pacific region.

However, the low adoption of advanced diabetic technology products, the high cost of manufacturing products, and the lack of awareness of diabetic patients about the advanced diabetic treatment solutions are restraining the growth of the insulin delivery devices market in the Asia-Pacific region.

This research report on the APAC Insulin Delivery Devices Market has been segmented and sub-segmented into the following categories:

By Type: 

  • Insulin Syringes
  • Insulin Pens
  • Insulin Pen Needles
  • Insulin Pumps
  • Insulin Jet Injectors

By Application: 

  • Type I Diabetes
  • Type II Diabetes

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, the insulin delivery devices market in the APAC region is estimated to occupy a significant share in the global market during the forecast period. However, the Asia Pacific is expected to grow at the fastest rate of 9.10 percent during the projected period.  The market growth is projected to be driven by the growing geriatric population, the prevalence of diabetes, and improving healthcare infrastructure. 

The market is highly concentrated, with only a few players controlling a substantial portion of the market in the region. The insulin syringe market, on the other hand, is highly fragmented, with several local companies. The Insulin delivery device market has been rising in developing countries such as China, Japan, and India, owing to the population's unsustainable diet. Furthermore, global vendors are expanding their operations in the Asia Pacific region and providing top-of-the-line items for diabetes treatment, which is a major driver of growth.

The China insulin delivery devices market is estimated to grow at a promising CAGR from 2021 to 2026 due to the increasing GDP, a huge population base suffering from diabetes, and raising awareness among individuals.

Japan accounted for 28% of the total market share In the Asia-Pacific insulin delivery devices market in 2020. The growing geriatric population in Japan is pushing the demand for insulin delivery devices. Changing lifestyle changes and a high level of disposable income among the population are major causes of boosting insulin delivery device sales. Insulin was once thought to be a therapy option only for type-1 diabetics. On the other hand, Insulin has been used by many type-2 patients as a therapeutic option over the years.

On the other hand, the Indian insulin delivery device market is anticipated to account for a moderate share and contribute to the APAC regional market growth. Children make up a sizable portion of diabetes type 1 patients. The invention of an insulin jet injector, a painless insulin administration device, was born out of a need for an alternative to the conventional needle-based delivery technique, which is uncomfortable. The majority of insulins are produced in the form of cartridges, making them easily accessible. These devices offer all of the features of reusable pens and are more cost-effective in the long term because the cartridges are less expensive than disposable insulin pens.

KEY MARKET PLAYERS:

Companies playing a dominant role in the Asia Pacific Insulin Delivery Devices Market profiled in this report are Becton, Dickinson, and Company (U.S.), Sanofi (France), Novo Nordisk A/S (Denmark), Julphar (U.A.E.), Eli Lilly and Company (U.S.), Biocon Ltd. (India), Ypsomed AG (Switzerland), Wockhardt Ltd. (India), B. Braun Meselgen AG (Switzerland) and Biodel Inc. (U.S.).

1. Introduction                                                                 

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Introduction                                                               

                5.2 Type                                                              

                                5.2.1 Introduction                                           

                                5.2.2 Insulin Syringes                                     

                                5.2.3 Insulin Pens                                            

                                5.2.4 Insulin Pen Needles                                            

                                5.2.5 Insulin Pumps                                        

                                5.2.6 Insulin Jet Injectors                                             

                5.3 Application                                                 

                                5.3.1 Introduction                                           

                                5.3.2 Type I Diabetes                                     

                                5.3.3 Type II Diabetes                                    

6. Geographical Analysis                                                                              

                6.3 Asia-Pacific                                                 

                                6.3.1 Introduction                                           

                                6.3.2 China                                         

                                6.3.3 India                                          

                                6.3.4 Japan                                         

                                6.3.5 Australia                                   

                                6.3.6 Soth Korea                                              

7. Strategic Analysis                                                                       

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis                                                                        

                8.1 Sanofi (France)                                                         

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                             

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Novo Nordisk A/S (Denmark)                                                             

                8.3 Eli Lilly and Company (U.S.)                                                  

                8.4 Biocon Ltd. (India)                                                   

                8.5 Julphar (U.A.E.)                                                        

                8.6 Ypsomed AG (Switzerland)                                                  

                8.7 Becton, Dickinson and Company (U.S.)                                                          

                8.8 Wockhardt Ltd. (India)                                                           

                8.9 B. Braun Meselgen AG (Switzerland)                                                              

                8.10 Biodel Inc. (U.S.)                                                    

9. Competitive Landscape                                                                           

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10. Expert Opinions                                                                        

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Insulin Delivery Devices Market, By Region, From 2021 to 2026 (USD Million)
  2. Asia-Pacific Insulin Delivery Devices Market, By Type, From 2021 to 2026 (USD Million)
  3. Asia-Pacific Insulin Syringes Market, By Region, From 2021 to 2026 (USD Million)
  4. Asia-Pacific Insulin Pens Market, By Region, From 2021 to 2026 (USD Million)
  5. Asia-Pacific Insulin Pen Needles Market, By Region, From 2021 to 2026 (USD Million)
  6. Asia-Pacific Insulin Pumps Market, By Region, From 2021 to 2026 (USD Million)
  7. Asia-Pacific Insulin Jet Injectors Market, By Region, From 2021 to 2026 (USD Million)
  8. Asia-Pacific Insulin Delivery Devices Market, By Application, From 2021 to 2026 (USD Million)
  9. Asia-Pacific Type I Diabetes of Insulin Delivery Devices Market, By Region, From 2021 to 2026 (USD Million)
  10. Asia-Pacific Type II Diabetes of Insulin Delivery Devices Market, By Region, From 2021 to 2026 (USD Million)
  11. China Insulin Delivery Devices Market, By Type, From 2021 to 2026 (USD Million)
  12. China Insulin Delivery Devices Market, By Application, From 2021 to 2026 (USD Million)
  13. India Insulin Delivery Devices Market, By Type, From 2021 to 2026 (USD Million)
  14. India Insulin Delivery Devices Market, By Application, From 2021 to 2026 (USD Million)
  15. Japan Insulin Delivery Devices Market, By Type, From 2021 to 2026 (USD Million)
  16. Japan Insulin Delivery Devices Market, By Application, From 2021 to 2026 (USD Million)
  17. Australia Insulin Delivery Devices Market, By Type, From 2021 to 2026 (USD Million)
  18. Australia Insulin Delivery Devices Market, By Application, From 2021 to 2026 (USD Million)
  19. South Korea Insulin Delivery Devices Market, By Type, From 2021 to 2026 (USD Million)
  20. South Korea Insulin Delivery Devices Market, By Application, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample